Evidence map›Paper›PMID 33558085›Full record

ArticleTransplantation proceedings2021

SARS-CoV2/COVID-19 Infection in Transplant Recipients and in Patients on the Organ Transplant Waiting List in Colombia.

Yazmin R Arias-Murillo, Carlos A Benavides-V, María A Salinas-N, Karime Osorio-Arango, Carolina Plazas-Sierra, Jorge A Cortés

Open access · greenAbstract read
In one paragraph

Article in Transplantation proceedings, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. COVID-19 and solid organ transplantation: Finding the right balance.Transplantation reviews (Orlando, Fla.) · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yazmin R Arias-MurilloCoordination of the National Donation and Transplant Network, Blood Bank, Transfusion, and Transplant Research Group, Direction of Public Health Networks, Instituto Nacional de Salud, Bogotá, Colombia. Electronic address: yarias@ins.gov.co.
Carlos A Benavides-VFundación Cardioinfantil, Transplant Surgeon, Bogotá, Colombia.
María A Salinas-NCoordination of the National Donation and Transplant Network, Blood Bank, Transfusion, and Transplant Research Group, Direction of Public Health Networks, Instituto Nacional de Salud, Bogotá, Colombia.
Karime Osorio-ArangoInstituto de Evaluación Tecnológica en Salud (IETS), Bogotá, Colombia.
Carolina Plazas-SierraCoordination of the National Donation and Transplant Network, Blood Bank, Transfusion, and Transplant Research Group, Direction of Public Health Networks, Instituto Nacional de Salud, Bogotá, Colombia.
Jorge A CortésDepartment of Internal Medicine and Infectious Diseases Research Group, School of Medicine, Universidad Nacional de Colombia, National University Hospital of Colombia, Bogotá, Columbia.
Instituto Nacional de Salud · COInstitute of Cardiology · COUniversidad Nacional de Colombia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess our determination to continue transplant activity in Colombia during the coronavirus disease 2019 (COVID-19) pandemic, this study seeks to describe the risk of infection and mortality of transplanted patients vs those on the waiting list. Therefore, a descriptive study of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2)/COVID-19 infection in transplant recipients and patients on the waiting list was conducted. The data sources were the information systems of the Instituto Nacional de Salud of Colombia: National Donation and Transplant Information System, the National Public Health Surveillance System, and the National COVID-19 Data Repository. Characteristics of the patients who tested positive were analyzed, and the mortality rate was determined. An Real Time-PCR test for SARS-CoV-2/COVID-19 was performed in 7% of the transplant recipients included in this study, and 14.8% of those recipients tested positive. Among patients on the waiting list, 15.2% were tested, and 16.7% showed positive results. Overall, 1% (84/8108) of the transplant recipients and 2.5% (74/2926) of patients on the waiting list were infected with SARS-CoV-2/COVID-19. There were no differences in mortality between these groups (P = .8748). In conclusion, with the data obtained so far, the hospital availability, and the adoption of safety protocols in the institutions, our findings can support the continuity of the transplant activities in this country.

Indexed as

Organ TransplantationAdultAgedColombiaCOVID-19FemaleHospital MortalityHumansMaleMiddle AgedPandemicsRegistriesSARS-CoV-2Waiting Lists

Identifiers

PMID33558085
PMCPMC7805389
OpenAlexW3119931217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.